ARGS: Argos Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Argos Therapeutics, Inc.

NASDAQ:ARGS

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$0.27
Loss Chance
58.7%
0.45JITTA SCORE
n/a
Jitta Ranking
Biotechnology
0 / 422
Healthcare
0 / 1
United States
?
4,134 / 4,151
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Amgen
NASDAQ:AMGN
6.24
$328.26
36.38%
Arena Pharmaceuticals
NASDAQ:ARNA
0.01
$99.99
100.00%
Biogen
NASDAQ:BIIB
5.83
$188.83
10.17%
Celgene Corporation
NASDAQ:CELG
8.55
$108.24
17.72%
Jitta Factors
Growth Opportunity (40)
Recent Business Performance (70)
Financial Strength (0)
Return to Shareholders (10)
Competitive Advantage (12)
Jitta Signs
Revenue and EarningEarning loss detected in 2017
Operating MarginDeclined
Recent Business PerformanceEarning decline 12.59% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.45
n/a
1.54
164.41%
3.20
100.00%
Biotechnology
6.24
36.38%
0.01
100.00%
5.83
10.17%
COMPANY DESCRIPTION
Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. Its product candidates include rocapuldencel-T, which is in Phase III clinical trial for the treatment of metastatic renal cell carcinoma. The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is based in Durham, North Carolina.
www.argostherapeutics.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.